OxyContin manufacturer Purdue Pharma won court approval for an opioid-related settlement plan of at least $7.4 billion, clearing its path to exit from a six-year bankruptcy and resolve mass lawsuits against the company for fueling addiction.
Becky Yerak is a Bankruptcy Reporter at The Wall Street Journal. She specializes in finance and trading, covering critical developments in the bankruptcy landscape and its implications for the market. Becky has been featured in Financial News, MarketWatch, Yahoo Finance, LiveMint, and MSN.